Mark Holodniy
Academic Appointments
- Professor - Med Center Line, Medicine - Infectious Diseases
Key Documents
Contact Information
-
Clinical Offices
Infectious Disease 3801 Miranda Ave MC 132 VA Palo Alto Health Care System Palo Alto, CA 94304 Tel Work (650) 852-3408 Fax (650) 858-3978
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Infectious Disease
Administrative Appointments
- Member, Medical School Faculty Senate (1999 - 2002)
- Member, Administrative Panel on Biosafety (1995 - 2013)
Honors and Awards
- Fellow, Infectious Disease Society of America (2005)
- Divisional Award for Exceptional Contributions in Education in the Division of Infectious Disease, Department of Medicine (2004)
- Infectious Diseases Teaching Award, Division of Infectious Diseases (2004)
- HIV Program Clinical Excellence Award, Department of Veterans Affairs (2001)
- Infectious Diseases Teaching Award, Division of Infectious Diseases (1997)
- Fellow, American College of Physicians (1996)
Professional Education
| Fellowship: | Stanford University School of Medicine CA (1990) |
| Board Certification: | Infectious Disease, American Board of Internal Medicine (1990) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1988) |
| Internship: | Good Samaritan Regional Medical Center AZ (1986) |
| Medical Education: | Northwestern Memorial Hospital IL (1985) |
| BS: | Seattle University, Biology (1980) |
Graduate & Fellowship Program Affiliations
Community and International Work
- Tri-national OPTIMA Trial, International
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
My research program is currently focused in three areas: 1) translational research (HCV/HIV viral evolution and antiviral resistance prevalence and development), 2) HIV/HCV clinical trials (diagnostic assay/medical device, antiretrovirals, ARVs and immunomodulators), and 3) health services research focusing on cost effectiveness of HIV antibody and ARV resistance testing and ARV utilization and clincal outcome.
Publications
- Concurrent outbreaks with co-infection of norovirus and Clostridium difficile in a long-term-care facility. Epidemiol Infect. 2013: 1-6
- Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States. PLoS One. 2013; (3): e58975
- Dengue surveillance in Veterans Affairs healthcare facilities, 2007-2010. PLoS Negl Trop Dis. 2013; (3): e2040
- Health-related Quality of Life Assessment after Antiretroviral Therapy: A Review of the Literature. Drugs. 2013
- Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients. PLoS One. 2013; (4): e60387
- Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review. PLoS One. 2013; (3): e59551
Help